| AR101 oral immunotherapy for peanut allergy PALISADE Group of Clinical Investigators New England Journal of Medicine 379 (21), 1991-2001, 2018 | 634 | 2018 |
| New-onset IgG autoantibodies in hospitalized patients with COVID-19 SE Chang, A Feng, W Meng, SA Apostolidis, E Mack, M Artandi, L Barman, ... Nature communications 12 (1), 5417, 2021 | 443 | 2021 |
| Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 596 (7872), 410-416, 2021 | 426 | 2021 |
| Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination K Röltgen, SCA Nielsen, O Silva, SF Younes, M Zaslavsky, C Costales, ... Cell 185 (6), 1025-1040. e14, 2022 | 411 | 2022 |
| Molecular and cellular mechanisms of food allergy and food tolerance RS Chinthrajah, JD Hernandez, SD Boyd, SJ Galli, KC Nadeau Journal of Allergy and Clinical Immunology 137 (4), 984-997, 2016 | 377 | 2016 |
| Omalizumab facilitates rapid oral desensitization for peanut allergy AJ MacGinnitie, R Rachid, H Gragg, SV Little, P Lakin, A Cianferoni, ... Journal of Allergy and Clinical Immunology 139 (3), 873-881. e8, 2017 | 314 | 2017 |
| Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study RS Chinthrajah, N Purington, S Andorf, A Long, KL O'Laughlin, SC Lyu, ... The Lancet 394 (10207), 1437-1449, 2019 | 262 | 2019 |
| Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial DM Fleischer, M Greenhawt, G Sussman, P Bégin, A Nowak-Wegrzyn, ... Jama 321 (10), 946-955, 2019 | 259 | 2019 |
| Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial S Andorf, N Purington, WM Block, AJ Long, D Tupa, E Brittain, AR Spergel, ... The lancet Gastroenterology & hepatology 3 (2), 85-94, 2018 | 235 | 2018 |
| Food allergy across the globe V Sampath, EM Abrams, B Adlou, C Akdis, M Akdis, HA Brough, S Chan, ... Journal of Allergy and Clinical Immunology 148 (6), 1347-1364, 2021 | 215 | 2021 |
| Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study SM Jones, EH Kim, KC Nadeau, A Nowak-Wegrzyn, RA Wood, ... The Lancet 399 (10322), 359-371, 2022 | 193 | 2022 |
| Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergy S Chinthrajah, S Cao, C Liu, SC Lyu, SB Sindher, A Long, V Sampath, ... JCI insight 4 (22), 2019 | 164 | 2019 |
| Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, ... Allergy 76 (3), 735-750, 2021 | 144 | 2021 |
| COVID‐19 pandemic: practical considerations on the organization of an allergy clinic—an EAACI/ARIA Position Paper O Pfaar, L Klimek, M Jutel, CA Akdis, J Bousquet, H Breiteneder, ... Allergy 76 (3), 648-676, 2021 | 135 | 2021 |
| Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system CM Warren, TT Snow, AS Lee, MM Shah, A Heider, A Blomkalns, B Betts, ... JAMA network open 4 (9), e2125524-e2125524, 2021 | 134 | 2021 |
| Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets JF Ryan, R Hovde, J Glanville, SC Lyu, X Ji, S Gupta, RJ Tibshirani, ... Proceedings of the National Academy of Sciences 113 (9), E1286-E1295, 2016 | 134 | 2016 |
| Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergy RA Hoh, SA Joshi, JY Lee, BA Martin, S Varma, S Kwok, SCA Nielsen, ... Science immunology 5 (45), eaay4209, 2020 | 121 | 2020 |
| Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives V Sampath, G Rabinowitz, M Shah, S Jain, Z Diamant, M Jesenak, ... Allergy 76 (6), 1640-1660, 2021 | 117 | 2021 |
| Climate change and global health: a call to more research and more action I Agache, V Sampath, J Aguilera, CA Akdis, M Akdis, M Barry, ... Allergy 77 (5), 1389-1407, 2022 | 109 | 2022 |
| A phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multifood allergic individuals S Andorf, N Purington, D Kumar, A Long, KL O'Laughlin, S Sicherer, ... EClinicalMedicine 7, 27-38, 2019 | 108 | 2019 |
